0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Embedded Video Item Thumbnail PAREA: psychedelic-assisted therapies in Europe
Related Embedded Video Item Thumbnail SA TAIP seminar | Tadeusz Hawrot - "Psychedelic advances in the EU"
Related Embedded Video Item Thumbnail Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality
Related Embedded Video Item Thumbnail Addressing psychological distress in palliative care; the EU funded PsyPal project on psychedelic therapy | EUHPP webinar
Related Embedded Video Item Thumbnail PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – Tadeusz Hawrot

Our Work

About
Why

Contact

tadeusz@parea.eu

© Parea 2024 | Privacy Policy